| Ytd | 54.43% | |
| 1y | 62.52% |
| Open | 9.38 | Prev Close | 9.42 | Low | 9.30 | High | 9.59 | Mkt Cap | 1.59B |
| Vol | 905.91K | Avg Vol | 1.86M | EPS | -3.13 | P/E | -3.01 | Forward P/E | 4.27 |
| Beta | 1.62 | Short Ratio | 8.17 | Inst. Own | 80.75% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 9.33 | 200-d Avg | 7.94 | 1yr Est | 21.56 |
VIR News
Vir Biotechnology is entering a catalyst-rich period with key clinical trial readouts from the ECLIP
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointmen
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company wi
Vir Biotechnology develops immunology-based therapies for infectious diseases, backed by collaborati
Vir Biotechnology develops antibody and RNA-based therapies for infectious diseases, leveraging part
Vir Biotechnology is rated a buy, supported by a strong cash position, pivotal late-stage pipeline,
Vir Biotechnology, Inc. (VIR) Presents at Bank of America Global Healthcare Conference 2026 Transcri
Vir Biotechnology, Inc. (VIR) Q1 2026 Earnings Call Transcript
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate up
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that it will
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that its globa
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the first
72,559 shares were sold for a total transaction value of ~$664,000 on April 6, 2026. This sale repre
Vir Biotechnology, Inc. (NASDAQ: VIR - Get Free Report) CEO Backer Marianne De sold 72,559 shares of
Citigroup Inc. reduced its position in Vir Biotechnology, Inc. (NASDAQ: VIR) by 22.2% in the undefin
Wall Street analysts changed outlook on top names. For full view of changes, including upgrades/down
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that members o
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage biopharmaceu
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage biopharmaceu
Vir Biotechnology, Inc. surges on positive Phase 1 data for VIR-5500 and a major global partnership
(Editor’s note: The future prices of benchmark tracking ETFs, the lede, the economic data, and the h
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings
During the session on Thursday, 461 stocks hit new 52-week lows.
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral t
During Thursday, 849 stocks hit new 52-week lows.
On Monday, 147 stocks hit new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.
Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly e